The Effects of Rimexolone 1% in Postoperative Inflammation after Cataract Extraction. A Double-Masked Placebo-Controlled Study

Aim

A multicentre, randomized, placebo-controlled double-masked study was conducted to assess the efficacy and safety of Rimexolone 1% eye drops in reducing inflammation after cataract surgery and intra-ocular lens implantation.

Methods

Rimexolone 1% (124 patients) or placebo (58 patients) was given, four times a day for 14 days starting 22-34 hours after surgery. All patients also received tobramycin 0.3% four times a day for 7 days. The clinical signs of ocular inflammation were recorded on days 1, 3, 8, 15 and 17 or 18.

Results

Rimexolone 1% markedly decreased the mean inflammation severity scores, and the sum of clinical assessments of cells and flare in the anterior chamber compared with placebo at each assessment. In addition, the percentage of patients with no anterior chamber inflammation was significantly higher with Rimexolone 1% than with the placebo at each assessment. All these results were statistically significant. Intra-ocular pressure did not rise after treatment with Rimexolone 1%.

Conclusions

The results suggest that Rimexolone 1% ophthalmic solution is an effective and safe steroidal anti-inflammatory agent for topical use following cataract surgery and intraocular lens implantation.

[Comparative study of corneal radial centripetal and centrifugal incisions]

The author presents a comparative study about the efficacity of centripetal incisions compared with centrifugal incisions. Centripetal incision is the best technic.

[Retrobulbar anaesthesia in cataract surgery revisited]

Retrobulbar anaesthesia in cataract surgery is advocated so as to decrease anaesthetic risk. The technique of anaesthesia was studied in 100 patients. The study was based on two principles: firstly, it was the anaesthetist who performed the retrobulbar anaesthesia; secondly, retrobulbar anaesthesia was a matter of deliberate choice and not done upon contra-indication of general anaesthesia. After describing the means used in obtaining anaesthesia, akinesia and efficient hypotonia of the eye, the results of the series are reported. The advantages of retrobulbar anaesthesia are discussed. The absence of noxious side-effects is stressed. This anaesthetic technique should be used more often regardless of the patient's condition.